Prophylactic use of filgrastim with ABVD and BEACOPP chemotherapy regimens for Hodgkin lymphoma.

Clinical lymphoma & myeloma

Volumn 8 Suppl 2, Issue , 2007, Pages

  Wedgwood, Amanda ^a   Younes, Anas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABVD PROTOCOL; ANTINEOPLASTIC AGENT; BEACOPP PROTOCOL; BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE;

CLINICAL TRIAL; HODGKIN DISEASE; HUMAN; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CLINICAL TRIALS AS TOPIC; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FILGRASTIM; HODGKIN DISEASE; HUMANS; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

MLCS; MLOWN;

EID: 40949131869     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2007.s.035     Document Type: Review

References (26)